Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of teriparatide off-label: our experience and review of literature.

Literature DB >> 28740522

Use of teriparatide off-label: our experience and review of literature.

Emanuele Ciurlia¹, Paolo Tranquilli Leali¹, Carlo Doria¹.

Abstract

The aim of this paper is to report our experience and to present a review of literature about the use of teriparatide off-label in the therapy of non-unions. Teriparatide is used exclusively in treatment of osteoporosis and to prevent bone fracture because it has a positive effect on bone strength and architecture. The use of teriparatide in non-unions is described as effective in numerous case report.

Entities: Chemical Disease

Keywords: bone remodeling; non-union; osteoporosis; teriparatide

Year: 2017 PMID： 28740522 PMCID： PMC5505711 DOI： 10.11138/ccmbm/2017.14.1.028

Source DB: PubMed Journal: Clin Cases Miner Bone Metab ISSN： 1724-8914

46 in total

1. Weekly teriparatide administration for the treatment of delayed union: a report of two cases.

Authors: Hisakazu Tachiiri; Yoshiki Okuda; Takahito Yamasaki; Torao Kusakabe
Journal: Arch Osteoporos Date: 2014-04-29 Impact factor: 2.617

2. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women.

Authors: Peter Peichl; Lukas A Holzer; Richard Maier; Gerold Holzer
Journal: J Bone Joint Surg Am Date: 2011-09-07 Impact factor: 5.284

3. Atrophic femoral nonunion successfully treated with teriparatide.

Authors: S Giannotti; V Bottai; G Dell'Osso; G de Paola; E Pini; G Guido
Journal: Eur J Orthop Surg Traumatol Date: 2012-12-09

4. Teriparatide: an unexpected adjunct for the treatment of a long-standing infected elbow prosthesis prevented arm amputation.

Authors: Maria Mouyis; Halina Fitz-Clarence; Jessica Manson; Coziana Ciurtin
Journal: Clin Rheumatol Date: 2015-03-06 Impact factor: 2.980

5. Safety and effectiveness of teriparatide vs alendronate in postmenopausal osteoporosis: a prospective non randomized clinical study.

Authors: Gianfilippo Caggiari; Paolo Tranquilli Leali; Giulia Raffaella Mosele; Leonardo Puddu; Francesca Badessi; Carlo Doria
Journal: Clin Cases Miner Bone Metab Date: 2017-02-10

6. Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide.

Authors: Jakob Holm; Pia Eiken; Lars Hyldstrup; Jens-Erik Beck Jensen
Journal: Endocr Pract Date: 2014-10 Impact factor: 3.443

7. PTH differentially regulates expression of RANKL and OPG.

Authors: John C Huang; Takeshi Sakata; Laura L Pfleger; Margaret Bencsik; Bernard P Halloran; Daniel D Bikle; Robert A Nissenson
Journal: J Bone Miner Res Date: 2003-12-16 Impact factor: 6.741

8. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.

Authors: P M McSheehy; T J Chambers
Journal: Endocrinology Date: 1986-02 Impact factor: 4.736

9. An atypical fracture in male patient with osteogenesis imperfecta.

Authors: Iñigo Etxebarria-Foronda; Pedro Carpintero
Journal: Clin Cases Miner Bone Metab Date: 2015-12-29

Review 10. Parathyroid hormone pulsatility: physiological and clinical aspects.

Authors: Silvia Chiavistelli; Andrea Giustina; Gherardo Mazziotti
Journal: Bone Res Date: 2015-01-27 Impact factor: 13.567

4 in total

1. Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study.

Authors: Paolo Tranquilli Leali; Massimo Balsano; Gianluca Maestretti; Matteo Brusoni; Veronica Amorese; Emanuele Ciurlia; Matteo Andreozzi; Gianfilippo Caggiari; Carlo Doria
Journal: Clin Cases Miner Bone Metab Date: 2017-10-25